Reach Us +1-218-451-2974


Chikako Wakana | OMICS International
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Chikako Wakana

BOOCS Clinic Fukuoka, 6-18 Tenya-machi, Hakata-ku, Fukuoka 812-0025, Japan.


Dr. Chikako Wakana, a distinguished expert, and the author has published several articles on Immunoreactivities, works in the Department of Immunology, BOOCS Clinic Fukuoka, 6-18 Tenya-machi, Hakata-ku, Fukuoka 812-0025, Japan.

Effects of Plasmalogen on Patients with Mild Cognitive Impairment: A Randomized, Placebo-Controlled Trial in Japan

Objective: It has been shown that plasmalogens (Pls) in the brain tissue and blood decrease among Alzheimer’s disease (AD) patients. We first confirmed the effects of Pls on animal AD models, and subsequently reported that the ingestion of 1 mg Pls was effective for AD patients in a randomized, placebo-controlled trial with mild cognitive imp... Read More»

Takehiko Fujino, Tatsuo Yamada, Takashi Asada, Midori Ichimaru, Yoshio Tsuboi, Chikako Wakana and Shiro Mawatari

Research Article: J Alzheimers Dis Parkinsonism 2018, 8:419

DOI: 10.4172/2161-0460.1000419

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article